Firstly, the FDA did not allow public discussion or hold a formal advisory committee meeting to discuss the data, despite previously saying they were "committed" to doing so. They simply said, in a statement to The BMJ, that the agency did not believe a meeting was necessary since they had already held numerous meetings themselves.
There is also a great deal of confusion about the product that has actually been approved. Approval was granted to the branded shot 'Comirnaty,' a product they say can be used "interchangeably" with the Pfizer-BioNtech shot. But the previous shot is still under EUA and is not FDA approved. On top of this, Pfizer says there are "insufficient stocks" of the newly licensed Comirnaty vaccine.
What the heck is going on here? Join us on this episode of Objective:Health as we delve into the implications.
For other health-related news and more, you can find us on:
And you can check out all of our previous shows (pre YouTube) here:
The information presented on this show is not intended to replace a qualified health care professional and is not intended as medical advice.
The intent is to share knowledge and information we encounter during our research and encourage you to do the same!
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.